The US Drug Enforcement Administration is proposing to reclassify marijuana from a Schedule I to a Schedule III drug, a move that could change how the federal government views medical marijuana use. This would make it easier for researchers to study the drug’s safety and efficacy as a medical treatment, though experts caution not to draw conclusions about its safety from this action. A drug’s classification can affect patient perceptions and willingness to consider its use in treatment.
Why powerful, secure networks are critical for first-class healthcare
Healthcare systems are facing significant challenges including staff shortages, cybersecurity threats, and budget constraints, according to a report by the Healthcare Information and Management Systems
